SynthesisFrontiers in oncology2024

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis.

Jile Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.